NCT03913559 2026-02-12
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
Phase 2 Terminated
St. Jude Children's Research Hospital
Korea University Guro Hospital
Case Comprehensive Cancer Center
University of Edinburgh
Milton S. Hershey Medical Center
Stanford University